SCHEMBL5872849

SCHEMBL5872849

Oc1nc(-c2n[nH]c3c(F)cccc23)sc1-c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 0.51
TRPM8 Q7Z2W7 3/20 0.34
CSF1R P07333 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
ALPL P05186 1/20 0.34
GAA P10253 1/20 0.34
IDO1 P14902 1/20 0.34
HPGD P15428 1/20 0.34
TTK P33981 1/20 0.34
MAPK10 P53779 1/20 0.34
MEN1 O00255 1/20 0.34
PDGFRB P09619 1/20 0.34
MAPT P10636 1/20 0.34
KIT P10721 1/20 0.34
FLT3 P36888 1/20 0.34
KMT2A Q03164 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
MAP4K4 O95819 1/20 0.33
FGFR1 P11362 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5768215 0.81 IDO1 (0.57) ALOX5KDM4EALDH1A1ALPLGAA
SCHEMBL5872907 0.71 RPA1 (0.44) ALOX5KDM4EALDH1A1HPGD
SCHEMBL4032541 0.71 PDPK1 (0.47) KDM4EALDH1A1ALPLGAAIDO1
SCHEMBL3138593 0.70 ALOX5 (0.80) ALOX5TRPM8ALDH1A1MEN1KMT2A
SCHEMBL5872957 0.70 APEX1 (0.44) CSF1RALDH1A1MEN1MAPTFLT3
SCHEMBL14158228 0.69 GPR84 (0.39) ALOX5CSF1RMAPK10FLT3MAP4K4
SCHEMBL9628733 0.68 ALOX5 (1.00) ALOX5TRPM8
SCHEMBL5773483 0.68 KDM4E (0.51) TRPM8KDM4EALDH1A1GAAHPGD
SCHEMBL5771654 0.67 ALDH1A1 (0.65) CSF1RKDM4EALDH1A1ALPLGAA
SCHEMBL5773580 0.67 L3MBTL1 (0.50) TRPM8KDM4EALDH1A1GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6984652-B2 Gyrase inhibitors WARNER-LAMBERT COMPANY LLC (US) 2006-01-10 US disclosed
US-20050250823-A1 Gyrase inhibitors YAGER KRAIG 2005-11-10 US disclosed
US-20050054697-A1 Gyrase inhibitors PFIZER INC. 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054697-A1 Gyrase inhibitors TOP1, TOP2A, TOP2B ALOX5 4495/4885TRPM8 4576/4885CSF1R 4011/4885
US-20050250823-A1 Gyrase inhibitors TOP1, TOP2A, TOP2B ALOX5 4495/4885TRPM8 4576/4885CSF1R 4011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.